The Association of Fever with Total Mechanical Ventilation Time in Critically Ill Patients

Dong Won Park; Moritoki Egi; Masaji Nishimura; Youjin Chang; Gee Young Suh; Chae-Man Lim; Jae Yeol Kim; Keiichi Tada; Koichi Matsuo; Shinhiro Takeda; Ryosuke Tsuruta; Takeshi Yokoyama; Seon-Ok Kim; Younsuck Koh

doi:10.3346/jkms.2016.31.12.2033

Journal List > J Korean Med Sci > v.31(12) > 1023185

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Park, Egi, Nishimura, Chang, Suh, Lim, Kim, Tada, Matsuo, Takeda, Tsuruta, Yokoyama, Kim, Koh, and Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group in Japan-Korea Intensive Care Study (JAKOICS) Group: The Association of Fever with Total Mechanical Ventilation Time in Critically Ill Patients

Original Article

Emergency & Critical Care Medicine

Journal of Korean Medical Science 2016; 31(12): 2033-2041.

Published online: 10 October 2016

DOI: https://doi.org/10.3346/jkms.2016.31.12.2033

The Association of Fever with Total Mechanical Ventilation Time in Critically Ill Patients

Dong Won Park¹

, Moritoki Egi²

, Masaji Nishimura³

, Youjin Chang⁴

, Gee Young Suh⁵

, Chae-Man Lim⁶

, Jae Yeol Kim⁷

, Keiichi Tada⁸

, Koichi Matsuo⁹

, Shinhiro Takeda¹⁰

, Ryosuke Tsuruta¹¹

, Takeshi Yokoyama¹², Seon-Ok Kim¹³

, Younsuck Koh⁶

; Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group in Japan-Korea Intensive Care Study (JAKOICS) Group

¹Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

²Department of anesthesiology, Kobe university hospital, Kobe, Japan.

³Department of Emergency and Critical Care Medicine, Tokushima University Hospital, Tokushima, Japan.

⁴Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea.

⁵Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

⁶Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

⁷Department of Pulmonary and Critical Care Medicine, Chung-Ang University College of Medicine, Seoul, Korea.

⁸Department of Anesthesiology and Intensive Care Medicine, Hiroshima City Hospital, Hiroshima, Japan.

⁹Division of Intensive Care Unit, New Tokyo Hospital, Tokyo, Japan.

¹⁰Division of Intensive and Coronary Care Unit, Nippon Medical School Hospital, Tokyo, Japan.

¹¹Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Yamaguchi, Japan.

¹²Intensive Care Unit, Department of Anesthesiology, Teine Keijinkai Hospital, Sapporo, Japan.

¹³Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

Address for Correspondence: Younsuck Koh, MD. Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. yskoh@amc.seoul.kr

Received 1 June 2016 Accepted 6 September 2016

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

This research aims to investigate the impact of fever on total mechanical ventilation time (TVT) in critically ill patients. Subgroup analysis was conducted using a previous prospective, multicenter observational study. We included mechanically ventilated patients for more than 24 hours from 10 Korean and 15 Japanese intensive care units (ICU), and recorded maximal body temperature under the support of mechanical ventilation (MAX_MV). To assess the independent association of MAX_MV with TVT, we used propensity-matched analysis in a total of 769 survived patients with medical or surgical admission, separately. Together with multiple linear regression analysis to evaluate the association between the severity of fever and TVT, the effect of MAX_MV on ventilator-free days was also observed by quantile regression analysis in all subjects including non-survivors. After propensity score matching, a MAX_MV ≥ 37.5°C was significantly associated with longer mean TVT by 5.4 days in medical admission, and by 1.2 days in surgical admission, compared to those with MAX_MV of 36.5°C to 37.4°C. In multivariate linear regression analysis, patients with three categories of fever (MAX_MV of 37.5°C to 38.4°C, 38.5°C to 39.4°C, and ≥ 39.5°C) sustained a significantly longer duration of TVT than those with normal range of MAX_MV in both categories of ICU admission. A significant association between MAX_MV and mechanical ventilator-free days was also observed in all enrolled subjects. Fever may be a detrimental factor to prolong TVT in mechanically ventilated patients. These findings suggest that fever in mechanically ventilated patients might be associated with worse mechanical ventilation outcome.

Graphical Abstract

Keywords: Body Temperature, Intensive Care Units, Mechanical Ventilation, Fever

INTRODUCTION

Fever occurs in approximately half of all patients admitted to the intensive care unit (ICU) (1). The significance of fever varies in different clinical settings. Fever may arise as an adaptive response to infectious causes (2) or as a nonspecific finding along with a critical illness or inflammatory condition (3). An elevated body temperature within physiologically febrile range in infectious conditions has been shown to enhance host immune cell activity against pathogen (4 5) and confer a survival benefit in a number of animal models and in human data (6 7). However, fever may be a mediator of worsened clinical outcome in critically ill patients, and high or persistent fever has been associated with increased mortality (8 9 10).

Among mechanically ventilated patients, fever could have a detrimental effect on gas exchange, and increases in cardiac output and oxygen consumption driven by fever tend to worsen hypoxemia (11 12). Moreover, increased production of carbon dioxide may deteriorate minute ventilation requirements, resulting in failure to wean from mechanical ventilation (MV). Fever had been reported to worsen lung tissue injury by enhancing recruitment of neutrophils and oxygen toxicity in mechanically ventilated patients (13 14), and exacerbate ventilator-induced lung injury (15). Taken together, cumulative data suggest that fever may have negative impacts on MV outcome, resulting in unfavorable consequences in critically ill patients. However, ventilator-associated infection complication (16 17) accompanied by fever could be associated with increased ICU length of stay and mortality (18 19). These findings urge us to investigate whether there is an independent association of fever and length of MV in mechanically ventilated patients.

Recently, in a cohort study of mainly septic patients with acute lung injury, fever was found to be associated with a prolonged duration of MV (20). However, another study on patients with acute respiratory distress syndrome reported contradictory results that fever in early phase may be an important factor in determining favorable outcome (21). Thus, the aim of our present study was to evaluate the association of body temperature with MV duration in a heterogenous cohort of mechanically ventilated patients.

MATERIALS AND METHODS

Study design and patients

The study population comprised consecutively enrolled patients in a previous prospective, multicenter observational study in Korea and Japan designed to evaluate the association of fever and the use of antipyretic therapy with mortality in critically ill patients with and without infection (22). That study included patients admitted to ICU for more than 48 hours from 1 September 2009 to 30 November 2009, and excluded cases with post-cardiac arrest or acute brain injury.

This study was focused on the impact of body temperature on duration of MV in patients admitted to the ICU. The enrolled subjects were 882 critically ill patients who required MV for more than 24 hours from 10 Korean and 15 Japanese ICUs. To determine the degree of body temperature changes during MV, we defined maximum body temperature (MAX_MV) as the highest body temperature measured at any time under the support of MV. We firstly enrolled survived patients within 28 days after ICU admission and calculated total mechanical ventilation time (TVT) as the time from MV initiation up to 28 days after enrollment. As the effect of fever on TVT could be skewed by early deaths within 28 days, we enrolled survived patients within 28 days after ICU admission. We excluded those with MAX_MV < 36.5°C, and those for whom data about MV were incomplete (Fig. 1). Mechanical ventilator-free day (VFD) was also compared depending on the presence of fever in all enrolled subjects including non-survivors.

Fig. 1

Study design in survived subjects.

MV = mechanical ventilation, MAX_MV = maximum body temperature during MV.

Data collection

We recorded variables including age, gender, reason for ICU admission, duration of TVT, and the Acute Physiology and Chronic Health Evaluation II (APACHE II) scores. The category of ICU admission was classified as medical or surgical admission. The major reason of admission was categorized as cardiac or vascular disease, thoracic or respiratory disease, renal or metabolic disease, gastrointestinal tract disease, and other. We recorded four-hourly body temperature readings until either ICU discharge or 28 days after ICU admission. The measurement of body temperature was performed as previously described (22).

Statistical analysis

Descriptive statistics included means ± standard deviations for continuous variables and frequencies and percentages for categorical variables. Results were compared with t-test or Mann-Whitney U-test and the χ² test or Fisher’s exact test as appropriate.

To evaluate whether high body temperature resulted in prolonged TVT, we compared TVT between patients with a MAX_MV of 36.5°C to 37.4°C and those with a MAX_MV ≥ 37.5°C in each of medical and surgical admission. Propensity scores for each subject were generated using logistic regression analysis model to compute the probability of MAX_MV ≥ 37.5°C, compared to MAX_MV of 36.5°C to 37.4°C, based on the following 10 clinically relevant covariates: gender, age, APACHE II score, height, weight, history of traumas, transplantation, readmission, sepsis within 24 hours of ICU admission, and reason for admission. Propensity score matching was performed by Greedy matching with using a caliper of 0.2 standard deviations of the logit of the propensity score. The selected patients formed well-matched 1:2 pairs in medical admission and 1:1 pair in surgical admission (patients with a MAX_MV of 36.5°C to 37.4°C and those with a MAX_MV ≥ 37.5°C). In the propensity score matched cohort, TVT between patients with a MAX_MV ≥ 37.5°C and those with a MAX_MV of 36.5°C to 37.4°C was compared with Wilcoxon signed rank test or linear mixed model that accounted for the clustering of matching 1:2 pairs.

We hypothesized that high body temperature could be related to prolonged TVT. As the relationship between body temperature and TVT may not be linear, we treated body temperature as a categorical variable, and MAX_MV was analyzed in four range categories of 36.5°C to 37.4°C, 37.5°C to 38.4°C, 38.5°C to 39.4°C, and ≥ 39.5°C. Univariate and multivariate linear regression analyses were performed to examine how the severity of MAX_MV affects TVT in each of medical and surgical admission. We selected significant variables using a stepwise backward elimination procedure in multivariate models. The TVT was subjected to logarithmic transformation to achieve a normal distribution before being entered into the linear regression model.

To verify the impact of fever on TVT, we additionally analyzed the association of MAX_MV and VFD through multivariate analysis in all enrolled subjects including non-survivors. However, the distribution of VFD made it difficult to apply standard linear regression model, showing the high frequency of extreme outcome ( Supplementary Fig. 1). Quantile regression approach was fitted to better explain the effect of MAX_MV on VFD. We performed quantile regression analysis at 0.25 quantile and median for medical admission and at 0.1 and 0.25 quantile for surgical admission. The goodness-of-fit of the model was assessed as the pseudo R² . Variables were selected by backward elimination and standard errors for regression coefficients were obtained with the bootstrap method. All tests were two-sided, and a P value < 0.05 was considered significant. Data were analyzed using SPSS version 20.0 for Windows (SPSS Inc., Chicago, IL, USA) and SAS version 9.3 (SAS Institute, Cary, NC, USA).

Ethics statement

Data collection and data analysis for this study were approved by each of the local institutional ethics committees, and the institutional review board of Asan Medical Center approved this study (IRB No. 2009-0416). The requirement for informed consent was waived at each individual participating center.

RESULTS

Baseline characteristics of survived subjects with MV

A total of 769 patients were firstly included in our present analysis (Fig. 1). The demographic and clinical characteristics of the unmatched survived patients in each of medical and surgical admission are listed in Table 1. A MAX_MV ≥ 37.5°C was recorded in 283 (83.0%) patients among the 341 with medical admission, and in 301 (70.3%) among the 428 with surgical admission. Among patients with both categories of ICU admission, men were less frequently observed and the mean APACHE II score was higher in those with a MAX_MV ≥ 37.5°C than in those with a MAX_MV of 36.5°C to 37.4°C. There were no significant differences in other clinical variables between the patients with a MAX_MV ≥ 37.5°C and a MAX_MV of 36.5°C to 37.4°C in medical admission. In surgical admission cases, patients with a MAX_MV ≥ 37.5°C were older, tended to be from Japan, and were more likely to be associated with sepsis in the first day of ICU admission, compared to those with MAX_MV of 36.5°C to 37.4°C.

Table 1

Baseline characteristics in the unmatched, survived subjects

Variables	Medical admission (n = 341)				P value	Surgical admission (n = 428)				P value
	36.5℃–37.4℃ (n = 58)		≥ 37.5℃ (n = 283)			36.5℃–37.4℃ (n = 127)		≥ 37.5℃ (n = 301)
	No.	%	No.	%		No.	%	No.	%
Country					0.032					< 0.001
Japan	13	22.4	105	37.1		31	24.4	207	68.8
Korea	45	77.6	178	62.9		96	75.6	94	31.2
Gender (male)	26	44.8	103	36.4	0.228	56	44.1	102	33.9	0.022
Age, yr	65.7 ± 15.1		63.3 ± 16.2		0.338	59.3 ± 14.9		63.9 ± 13.3		0.002
APACHE II	19.2 ± 6.7		21.0 ± 6.7		0.063	11.8 ± 5.7		14.0 ± 5.5		< 0.001
Height	162.4 ± 9.0		161.6 ± 9.3		0.586	161.4 ± 9.4		161.1 ± 9.2		0.768
Weight	56.4 ± 10.6		58.4 ± 13.4		0.243	60.1 ± 11.7		60.0 ± 12.5		0.964
Trauma	0	0.0	12	4.2	0.298	1	0.8	12	4.0	0.292
Transplantation	1	1.7	5	1.8	1.000	9	7.1	7	2.3	0.033
Readmission	3	5.2	13	4.6	0.741	6	4.7	5	1.7	0.459
Sepsis within 24 hr	38	65.5	217	76.7	0.075	3	2.4	42	14.0	0.001
Reason for admission					0.314					0.005
Cardiac or vascular disease	9	15.5	45	15.9		100	78.7	180	59.8
Thoracic or respiratory disease	41	70.7	175	61.8		16	12.6	55	18.3
Renal or metabolic disease	5	8.6	18	6.4		3	2.4	10	3.3
Gastrointestinal tract disease	1	1.7	18	6.4		8	6.3	55	18.3
Other	2	3.5	27	9.5		0	0.0	1	0.3
Antipyretic therapy, any	4	6.9	189	66.8	< 0.001	21	16.5	208	69.1	< 0.001
RRT	12	20.7	57	20.1	0.524	6	4.7	52	17.3	< 0.001
ECMO	9	15.5	54	19.1	0.334	4	3.1	32	10.6	0.006

APACHE II = acute physiology and chronic health evaluation II, RRT = renal replacement therapy, ECMO = extracorporeal membrane oxygenation.

Baseline characteristics after propensity matching

After propensity matching, 94.8% of patients with a MAX_MV of 36.5°C to 37.4°C (n = 55) in medical admission were successfully matched 1:2 of patients with a MAX_MV ≥ 37.5°C. In patients with surgical admission, suitable propensity 1:1 matching was found for 117 (92.1%) of the 127 patients with a MAX_MV of 36.5°C to 37.4°C. Propensity matching successfully eliminated discordance that existed between the two temperature groups in this study (Table 2). As the only remaining unbalanced covariate was nationality, we performed additional propensity matching in survived subjects using all covariates including nationality (Supplementary Table 1).

Table 2

Baseline characteristics in the propensity-matched, survived subjects

Variables	Medical admission (1:2 matching)				P value	Surgical admission (1:1 matching)				P value
	36.5℃–37.4℃ (n = 55)		≥ 37.5℃ (n = 110)			36.5℃–37.4℃ (n = 117)		≥ 37.5℃ (n = 117)
	No.	%	No.	%		No.	%	No.	%
Country					0.027					< 0.001
Japan	12	21.82	43	39.09		30	25.64	65	55.56
Korea	43	78.18	67	60.91		87	74.36	52	44.44
Gender (male)	24	43.64	47	42.73	0.911	47	40.17	48	41.03	0.886
Age, yr	65.8 ± 15.1		64.6 ± 15.6		0.637	60.6 ± 14.4		60.7 ± 13.9		0.971
APACHE II	19.7 ± 6.4		19.9 ± 5.8		0.688	12.2 ± 5.6		12.0 ± 4.9		0.855
Height	161.8 ± 8.9		162.0 ± 9.9		0.999	161.6 ± 9.6		162.6 ± 9.5		0.394
Weight	56.3 ± 10.7		56.0 ± 13.1		0.875	60.6 ± 11.8		61.4 ± 10.7		0.591
Trauma	0	0.0	0	0.0	1.000	1	0.85	2	1.71	0.564
Transplantation	1	1.82	5	4.55	0.665	8	6.84	6	5.13	0.527
Readmission	3	5.45	3	2.73	0.401	4	3.42	4	3.42	1.000
Sepsis within 24 hr	38	69.09	76	69.09	1.000	3	2.56	4	3.42	0.705
Reason for admission					0.824					0.909
Cardiac or vascular disease	9	16.36	11	10		91	77.78	93	79.49
Thoracic or respiratory disease	39	70.91	82	74.55		15	12.82	16	13.68
Renal or metabolic disease	4	7.27	8	7.27		3	2.56	2	1.71
Gastrointestinal tract disease	1	1.82	3	2.73		8	6.84	6	5.13
Other	2	3.64	6	5.45		0	0	0	0.0

APACHE II = acute physiology and chronic health evaluation II.

Association of MAX_MV with TVT

In Table 3, the TVT was separately assessed in medical and surgical admission according to the MAX_MV value. In crude analysis, patients with a MAX_MV ≥ 37.5°C had a significantly longer TVT irrespective of the category of ICU admission, compared to those with a MAX_MV of 36.5°C to 37.4°C. After propensity matching, we found that the mean TVT of patients with a MAX_MV ≥ 37.5°C was also significantly associated with a prolonged TVT by 5.4 days in medical admission and by 1.2 days in surgical admission compared to those with a MAX_MV of 36.5°C to 37.4°C. We also performed propensity matching process using all covariates including nationality and obtained similar results, and patients with MAX_MV ≥ 37.5°C was proven again to be significantly related to prolonged TVT (Table 3).

Table 3

Comparison of total mechanical ventilation time according to the MAX_MV value in survived subjects

Variables		MAX_MV				P value
		36.5℃–37.4℃		≥ 37.5℃
		No.	Total MV time	No.	Total MV time
Medical admission
Crude^*		58	6.6 ± 6.5 4 (3–7)	283	10.7 ± 8.4 8 (5–15)	< 0.001
Propensity-matched set^†(1:2 matching)	Without nationality matching	55	6.5 ± 6.7 4 (3–7)	110	11.9 ± 8.5 9 (5–18)	< 0.001
Propensity-matched set^†(1:2 matching)	With nationality matching	52	6.6 ± 6.8 4 (3–7)	104	11.3 ± 8.4 8 (5–16)	< 0.001
Surgical admission
Crude^*		127	2.3 ± 2.5 2 (2–2)	301	4.7 ± 6.0 2 (2–4)	< 0.001
Propensity-matched set^‡(1:1 matching)	Without nationality matching	117	2.3 ± 2.6 2 (2–2)	117	3.5 ± 4.5 2 (2–3)	< 0.001
Propensity-matched set^‡(1:1 matching)	With nationality matching	93	2.3 ± 2.9 2 (2–2)	93	4.0 ± 5.9 2 (2–3)	0.001

Duration of mechanical ventilation are reported as means ± SD or as median (interquartile ranges).

MAX_MV = maximum body temperature during mechanical ventilation, MV = mechanical ventilation.

^*Mann-Whitney U-test; ^†Linear mixed model; ^‡Wilcoxon signed rank test.

Independent predictors of TVT

Univariate and multivariate predictors of prolonged TVT in the enrolled survived subjects are listed in Table 4. In univariate analysis, we obtained the mean estimated TVT by taking the antilog of the linear regression coefficient for the MAX_MV. As body temperature was stratified by four categories according to the MAX_MV values (36.5°C to 37.4°C, 37.5°C to 38.4°C, 38.5°C to 39.4°C, and ≥ 39.5°C), the mean estimated TVT in medical admission was 4.8, 6.6, 9.6, and 10.7 days, respectively. For the patients with surgical admission, we obtained values of 1.9, 2.7, 4.5, and 8.0 days, respectively, for the four categories of MAX_MV.

Table 4

Univariate and multivariate models for total mechanical ventilation time in survived subjects

Variables	Medical admission				Surgical admission
	Univariate analysis		Multivariate analysis		Univariate analysis		Multivariate analysis
	β (95% CI)	P value	β (95% CI)	P value	β (95% CI)	P value	β (95% CI)	P value
MAX_MV
36.5℃–37.4℃	0.0 (reference)		0.0 (reference)		0.0 (reference)		0.0 (reference)
37.5℃–38.4℃	0.323 (0.086, 0.560)	0.008	0.310 (0.077, 0.542)	0.009	0.313 (0.168, 0.458)	< 0.001	0.229 (0.091, 0.367)	0.001
38.5℃–38.4℃	0.700 (0.443, 0.957)	< 0.001	0.704 (0.451, 0.957)	< 0.001	0.843 (0.642, 1.045)	< 0.001	0.606 (0.408, 0.804)	< 0.001
≥ 39.5℃	0.811 (0.475, 1.146)	< 0.001	0.798 (0.465, 1.132)	< 0.001	1.418 (1.024, 1.812)	< 0.001	0.986 (0.602, 1.369)	< 0.001
Korea (vs. Japan)	−0.040 (−0.225, 0.144)	0.669	-	-	−0.261 (−0.400, −0.122)	< 0.001	-	-
Female (vs. male)	0.315 (0.137, 0.493)	0.001	0.259 (0.089, 0.430)	0.003	0.171 (0.026, 0.315)	0.021	-	-
Age, yr	0.004 (−0.001, 0.010)	0.111	0.006 (0.001, 0.011)	0.024	0.010 (0.005, 0.015)	< 0.001	0.005 (0.001, 0.010)	0.022
APACHE II	0.012 (−0.001, 0.025)	0.078	-	-	0.036 (0.025, 0.048)	< 0.001	-	-
Height	0.007 (−0.003, 0.017)	0.175	-	-	−0.001 (−0.008, 0.007)	0.879	-	-
Weight	0.003 (−0.004, 0.010)	0.384	-	-	0.000 (−0.006, 0.006)	0.987	-	-
Trauma	−0.272 (−0.748, 0.204)	0.262	-	-	0.338 (−0.069, 0.745)	0.103	-	-
Transplantation	0.342 (−0.325, 1.010)	0.314	-	-	−0.029 (−0.398, 0.341)	0.879	-	-
Readmission	−0.014 (−0.430, 0.401)	0.946	-	-	−0.006 (−0.449, 0.437)	0.978	-	-
Sepsis within 24 hr	0.301 (0.102, 0.501)	0.003	-	-	0.834 (0.620, 1.049)	< 0.001	0.537 (0.331, 0.743)	< 0.001
Reason for admission
Cardiac or vascular	−0.194 (−0.439, 0.051)	0.121	-	-	−0.129 (−0.310, 0.051)	0.159	−0.102 (−0.266, 0.061)	0.218
Thoracic/respiratory	0.0 (reference)				0.0 (reference)		0.0 (reference)
Renal/metabolic	−0.389 (−0.743, −0.036)	0.031	-	-	0.880 (0.471, 1.290)	< 0.001	0.711 (0.338, 1.084)	< 0.001
Gastrointestinal	−0.076 (−0.461, 0.309)	0.698	-	-	0.492 (0.257, 0.727)	< 0.001	0.168 (−0.053, 0.390)	0.136
Other	−0.301 (−0.620, 0.017)	0.064	-	-	−0.290 (−1.657, 1.077)	0.677	−0.805 (−2.047, 0.436)	0.203

CI = confidence interval, MAX_MV = maximum body temperature during mechanical ventilation, APACHE II = acute physiology and chronic health evaluation II.

Multivariate analysis for predicting factors related to prolonged duration of TVT was performed, adjusting marginal and significant variables in univariate analysis. For the patients with medical admission, patients with fever within three categories of MAX_MV of 37.5°C to 38.4°C, 38.5°C to 39.4°C, and ≥ 39.5°C sustained a significantly prolonged duration of TVT than those with MAX_MV of 36.5°C to 37.4°C (β = 0.310, 0.704, 0.798, and P value = 0.009, < 0.001, < 0.001, respectively). Female gender (β = 0.259, P value = 0.003) and age (β = 0.006, P value = 0.024) were significantly associated with a longer TVT in medical admission. For patients with surgical admission, all three categories of fever (MAX_MV of 37.5°C to 38.4°C, 38.5°C to 39.4°C, and ≥ 39.5°C) were also a significant predictor of increased TVT, compared to a normal MAX_MV range (β = 0.229, 0.606, 0.986, and P value = 0.001, < 0.001, < 0.001, respectively). Older age (β = 0.005, P value = 0.022), the presence of sepsis developed within the first day of ICU admission (β = 0.537, P value < 0.001) and renal/metabolic causes (β = 0.711, P value < 0.001) taking thoracic/respiratory causes as a reference were significantly associated with longer TVT in surgical admission.

Association of MAX_MV with VFD in all enrolled subjects

To clarify the impact of fever on TVT, we observed the relationship between MAX_MV and VFD in all enrolled subjects with non-survivors. Propensity score matching was performed in all subjects using all covariates including nationality (Supplementary Table 2). In propensity-matched analysis, we found that patients with a MAX_MV ≥ 37.5°C had significant shorter duration of VFD in both category of ICU admission, compared to those with a normal range of MAX_MV (Supplementary Table 3).

Table 5 shows the estimated coefficients of clinical variables from multivariate quantile regression analysis at percentiles of 0.1, 0.25 and 0.5 considering the distribution of VFD in all enrolled subjects including non-survivors (Supplementary Fig. 1). The effect of MAX_MV on VFD was significant at the twenty-fifth and fiftieth percentile in patients with medical admission. When all other covariates were controlled at the fiftieth percentile, patients with all three categories of fever (MAX_MV of 37.5°C to 38.4°C, 38.5°C to 39.4°C, and ≥ 39.5°C) in medical admission had significantly decreased VFD than those with normal range of MAX_MV, by 2.7 days, 8.3 days and 14.0 days, respectively (The model fit statistics Pseudo R² was 0.131). In patients with surgical admission, higher range of MAX_MV (38.5°C to 39.4°C, and ≥ 39.5°C) had a significant effect on decreased VFD at the twenty-fifth percentile relative to the reference range of 36.5°C to 37.4°C. In controlled condition of other covariates, patients with fever (MAX_MV of 38.5°C to 39.4°C, and ≥ 39.5°C) in surgical admission had significantly decreased VFD than those with normal MAX_MV range, by 4.0 days and 9.4 days at median quantile regression of VFD, respectively (Pseudo R² = 0.196).

Table 5

Multivariate quantile regression analysis for patient variables at the quantiles of mechanical ventilator-free days in all enrolled subjects

Quantile	Intercept	MAX_MV (vs. 36.5℃–37.4℃)			Country	Gender	Age, yr	APACHEII	Trauma	Sepsis within 24 hr	Reason for admission (vs. thoracic/respiratory)
Quantile	Intercept	37.5℃–38.4℃	38.5℃–38.4℃	≥ 39.5℃	Country	Gender	Age, yr	APACHEII	Trauma	Sepsis within 24 hr	Cardiac/vascular	Renal/metabolic	Gastrointestinal	Other
Medical admission
0.25
β	20.000	−13.000	−15.000	−15.000					16.000	−5.000	< 0.001	< 0.001	< 0.001	12.000
SE	2.754	3.579	2.267	2.300					6.755	1.137	1.861	3.172	3.819	3.444
P	< 0.001	< 0.001	< 0.001	< 0.001					0.018	< 0.001	1.000	1.000	1.000	0.001
Pseudo R² = 0.096
0.5
β	29.333	−2.667	−8.333	−14.000		−3.000		−0.333			2.667	4.000	5.667	6.000
SE	1.639	1.224	1.495	3.095		1.005		0.075			1.108	2.395	3.501	1.320
P	< 0.001	0.030	< 0.001	< 0.001		0.003		< 0.001			0.017	0.096	0.106	< 0.001
Pseudo R² = 0.131
Surgical admission
0.1
β	27.600	−0.400	−4.400	−16.000				−0.400		−14.000
SE	0.931	1.360	3.427	12.612				0.130		5.170
P	< 0.001	0.769	0.200	0.205				0.002		0.007
Pseudo R² = 0.246
0.25
β	26.545	−0.455	−4.000	−9.364				−0.091			< 0.001	−14.545	−0.636	6.182
SE	0.730	0.350	1.124	4.042				0.031			0.693	5.568	1.249	43.966
P	< 0.001	0.194	< 0.001	0.021				0.003			1.000	0.009	0.611	0.888
Pseudo R² = 0.196

The results shown are the obtained regression coefficients (β) with corresponding P values, which could be used to predict mechanical ventilator-free days at the distinct level of MAX_MV. Variables including height, weight, post-transplantation and readmission that showed no statistically significance in the multivariate quantile regression analysis were not indicated.

MAX_MV = maximum body temperature during mechanical ventilation, APACHE II = acute physiology and chronic health evaluation II, SE = bootstrapping standard error of regression coefficient in the multivariate quantile regression analysis.

DISCUSSION

This study showed that fever contributed to prolong TVT in our subjects regardless of ICU category. Fever was an independent predictor of prolonged duration of MV in two groups of survivors of both medical and surgical admission. In addition, fever was negatively associated with ventilator-free days in all enrolled subjects with non-survivors. These results suggest that fever should be considered a potential confounding factor on MV outcome to design future studies on the outcome of mechanically ventilated patients.

Similar to our present study, Netzer et al. (20) conducted a prospective cohort study on mechanically ventilated patients with acute lung injury. These authors demonstrated that an additional febrile day during the first week after acute lung injury was strongly related to delayed weaning from MV, but more than two thirds of the enrolled cases were related to sepsis. The strength of our investigation is that we confirmed the significant association of fever with prolonged TVT in heterogenous ventilated patients with diverse underlying conditions, almost unrelated to sepsis. We used propensity score matching to assess this issue in each category of ICU admission, as the type of ICU admission could influence the outcome. In addition, we demonstrated that the degree of body temperature in mechanically ventilated patients was significantly associated with a prolonged TVT. These are the main features of this study that deserve to be highlighted as they differentiate it from the study by Netzer et al. (20).

Moreover, to verify these findings, fever during MV was found to be related to worse MV outcome by decreasing VFD in mechanically ventilated patients even including non-survivors. Interestingly, the association of reduced VFD with fever was slightly clearer for ICU patients with surgical admission, showing higher pseudo R², than those with medical admission. This finding might be related to the difference in the presence of sepsis in the first day of ICU stay between both categories of ICU admission. About three quarters of medical admission had sepsis at admission to the ICU, but only 10% of those with surgical admission were without sepsis. Recent studies have suggested fever may have different clinical implications for ICU patients with and without sepsis (22 23 24). Lee et al. (22) showed that fever was associated with increased 28-day mortality in patients without sepsis but not in those with sepsis. Similar findings were observed in retrospective cohort study of Young et al. (23). High peak temperature in ICU patients without infection was associated with an increased risk of in-hospital mortality. These findings raised possibility that the presence of sepsis or infection may be an important determinant of ICU outcome. Although further studies on the impact of fever on MV outcome should be needed, it is important that our results confirmed significant association between fever and worse MV outcome including VFD regardless of ICU category.

As prolonged MV can lead to various potentially serious complications (25), reducing the time that ICU patients receive MV is crucial. However, to the best of our knowledge, no previous clinical trial has shown whether fever control could shorten the TVT and improve MV outcome. In a randomized trial, Bernard et al. (26) evaluated the effect of intravenous ibuprofen in 455 patients with severe sepsis. Reducing temperature in patients receiving MV resulted in decreases in heart rate and minute ventilation, although no survival benefit was seen. Moreover, antipyretic therapy using propacetamol reduced the energy expenditure index and oxygen consumption in a small study of mechanically ventilated patients with infection (11). A previous randomized trial also showed that patients receiving external cooling were more likely to have shock reversal and achieve hemodynamic stability, reducing the vasopressor dose by 50% in mechanically ventilated patients with septic shock, compared to control group (12). These results suggest that fever control may have beneficial impacts on MV outcome. A recent study of Young et al. (27) demonstrated that early use of acetamino-phen in critically ill patients with known or suspected infection did not show a benefit in terms of primary outcome; however, the length of ICU stay was reduced among survivors, in line with our results. However, the impact of fever control on MV outcome should be further elucidated in randomized trials on mechanically ventilated ICU patients.

Several limitations should be considered, because our analysis was conducted using data from a previous observational study (22). Although we found a significant relationship between fever and prolonged duration of MV, casual link cannot be assumed. Moreover, there was no standardization for protocols of weaning from MV contributing data to our analysis. Other potential factors also could affect the MV outcomes. Sepsis in the ICU setting is commonly accompanied with fever (28), which might increase the risk of organ dysfunction and critical illness polyneuropathy resulting in delayed weaning from MV (29). This pathologic condition could be the underlying cause of both MV duration and fever. Moreover, characteristics of fever including timing and duration of fever may also affect TVT and MV outcome (30). Interestingly, prolonged duration of MV has been also described for an independent risk factor for prolonged or long-lasting fever (10), which may explained in light of the high incidence of ventilator associated pneumonia (VAP). Previous literature reported that fever (≥ 38.0°C) in patients with VAP could persist for at least three days in more than one third of them (31), and the mean time to resolution of fever has been reported about 6 days (32). Thus, in evaluating the possible association of fever with MV outcome, the results should be interpreted with caution regarding the presence of VAP, which in turn, might prolong the need for MV. Meanwhile, body temperature measured in the present study could be influenced by various factors. More than half of ICU patients were treated with antipyretic therapy without specific protocols for treatment of fever across the participating ICUs. Additionally, about ten percent of enrolled ICU patients received lifesaving therapeutic modality including extracorporeal membrane oxygenation and renal-replacement therapy. These patients are more likely to experience heat loss through the extensive extracorporeal circuit, resulting in hypothermia (33 34). We only measured MAX_MV defined as maximal body temperature during MV, and did not cover if febrile-range MAX_MV was related to development of VAP in the current investigation. Thus, further research by using etiology and characteristics of fever needs to be conducted to elucidate the impact of fever on MV outcome.

Our current observations indicate that febrile patients with respiratory failure may have a significantly prolonged TVT compared to those with body temperatures within the normal range, regardless of ICU category. We also demonstrate that fever in mechanically ventilated patients is an independent risk factor for prolonged TVT, highlighting the importance of fever on MV outcome. Thus, fever in critically ill patients with MV appears to be significantly associated with worse MV outcome. Clinical implication of our results is that fever under the support of MV should be considered to design future researches on outcome of mechanically ventilated patients.

ACKNOWLEDGMENT

We acknowledge the assistance from The Korean Society of Critical Care Medicine and the Japanese Society of Intensive Care Medicine supported the travel expense for the following research committee members to JAKOICS meetings.

Korea: Byung Ho Lee (Department of Anesthesiology, St. Paul’s Hospital, Catholic University of Korea, Seoul); Jae Young Kwon (Department of Anesthesiology and Pain Medicine, Pusan National University School of Medicine, Busan); Jisook Park (School of Media, Seoul Women's University, Seoul); Kook Hyun Lee (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul); Kyoung Min Lee (Anesthesiology and Critical Cate Medicine, Konkuk University Hospital, Seoul); Seok-Hwa Yoon (Department of Anesthesiology and Pain Medicine, Chungnam National University Hospital, Daejeon); Shin Ok Koh (Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, Seoul); Sung Jin Hong and Ji Young Lee (Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul).

Japan: Daisuke Inui (Department of Emergency and Critical Care Medicine, Tokushima University Hospital, Tokushima); Keiji Tanaka and Takeshi Yamamoto (Division of Intensive and Coronary Care Unit, Nippon Medical School Hospital, Tokyo); Kenichi Ietsugu, Masanori Ito, and Shinsuke Saito (Tonami General Hospital, Toyama); Kenji Uehara, Satoshi Nogami, and Makoto Takatori (Department of Anesthesiology and Intensive Care Medicine, Hiroshima City Hospital, Hiroshima); Kentaro Dote (Intensive Care Division, Ehime University Hospital, Ehime); Kimitaka Tajimi and Toshiko Igarashi (Emergency & Critical Care Medicine, Akita University Graduate School of Medicine, Akita); Kiyoshi Morita (Department of Intensive Care, Okayama University Hospital, Okayama); Koji Hoshino and Naofumi Honda (Intensive Care Unit, Department of Anesthesiology, Teine Keijinkai Hospital, Sapporo); Koji Hosokawa and Nobuaki Shime (Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto); Masamitsu Sanui (Department of Anesthesiology and Critical Care Medicine, Saitama Medical Center, Jichi Medical University, Saitama); Naoko Okayama and Yasuyuki Kakihana (Division of Intensive Care Medicine, Kagoshima University Hospital, Kagoshima); Shigeki Fujitani (Department of Emergency and Critical Care Medicine, St. Marianna University, Kanagawa); Takuhiro Yamaguchi (Innovation of New Biomedical Engineering Center, Tohoku University, Sendai); Tomoki Nishiyama (Department of Anesthesiology and Critical Care, Kamagaya General Hospital, Kamagaya).

Notes

^DISCLOSURE The authors have no potential conflicts of interest to disclose.

^{AUTHOR CONTRIBUTION} Study plan: Koh Y, Egi M, Nishimura M. Coordination of patient enrollment and data collection: Egi M, Nishimura M, Chang Y, Suh GY, Lim CM, Kim JY, Tada K, Matsuo K, Takeda S, Tsuruta R, Yokoyama T, Koh Y. Management of data collection: Park DW, Egi M, Chang Y, Kim SO. Statistical analysis: Kim SO. Data interpretation: Park DW, Egi M, Nishimura M, Chang Y. Drafting the manuscript: Park DW, Egi M, Nishimura M, Koh Y. Review and approval of final manuscript: all authors.

References

1. Laupland KB, Shahpori R, Kirkpatrick AW, Ross T, Gregson DB, Stelfox HT. Occurrence and outcome of fever in critically ill adults. Crit Care Med. 2008; 36:1531–1535.

2. O’Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, Linden P, Maki DG, Nierman D, Pasculle W, et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med. 2008; 36:1330–1349.

3. Marik PE. Fever in the ICU. Chest. 2000; 117:855–869.

4. Jiang Q, Cross AS, Singh IS, Chen TT, Viscardi RM, Hasday JD. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect Immun. 2000; 68:1265–1270.

5. Kluger MJ, Kozak W, Conn CA, Leon LR, Soszynski D. The adaptive value of fever. Infect Dis Clin North Am. 1996; 10:1–20.

6. Brandts CH, Ndjavé M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet. 1997; 350:704–709.

7. Eyers S, Weatherall M, Shirtcliffe P, Perrin K, Beasley R. The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. J R Soc Med. 2010; 103:403–411.

8. Circiumaru B, Baldock G, Cohen J. A prospective study of fever in the intensive care unit. Intensive Care Med. 1999; 25:668–673.

9. Peres Bota D, Lopes Ferreira F, Mélot C, Vincent JL. Body temperature alterations in the critically ill. Intensive Care Med. 2004; 30:811–816.

10. Seguin P, Roquilly A, Mimoz O, Le Maguet P, Asehnoune K, Biederman S, Carise E, Malledant Y. AtlanRea Group. Risk factors and outcomes for prolonged versus brief fever: a prospective cohort study. Crit Care. 2012; 16:R150.

11. Gozzoli V, Treggiari MM, Kleger GR, Roux-Lombard P, Fathi M, Pichard C, Romand JA. Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intensive Care Med. 2004; 30:401–407.

12. Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, et al. Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med. 2012; 185:1088–1095.

13. Hasday JD, Garrison A, Singh IS, Standiford T, Ellis GS, Rao S, He JR, Rice P, Frank M, Goldblum SE, et al. Febrile-range hyperthermia augments pulmonary neutrophil recruitment and amplifies pulmonary oxygen toxicity. Am J Pathol. 2003; 162:2005–2017.

14. Rice P, Martin E, He JR, Frank M, DeTolla L, Hester L, O’Neill T, Manka C, Benjamin I, Nagarsekar A, et al. Febrile-range hyperthermia augments neutrophil accumulation and enhances lung injury in experimental gram-negative bacterial pneumonia. J Immunol. 2005; 174:3676–3685.

15. Suzuki S, Hotchkiss JR, Takahashi T, Olson D, Adams AB, Marini JJ. Effect of core body temperature on ventilator-induced lung injury. Crit Care Med. 2004; 32:144–149.

16. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. EPIC International Advisory Committee. JAMA. 1995; 274:639–644.

17. Kwak YG, Lee SO, Kim HY, Kim YK, Park ES, Jin HY, Choi HJ, Jeong SY, Kim ES, Ki HK, et al. Risk factors for device-associated infection related to organisational characteristics of intensive care units: findings from the Korean Nosocomial Infections Surveillance System. J Hosp Infect. 2010; 75:195–199.

18. Hayashi Y, Morisawa K, Klompas M, Jones M, Bandeshe H, Boots R, Lipman J, Paterson DL. Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis. 2013; 56:471–477.

19. Muscedere J, Sinuff T, Heyland DK, Dodek PM, Keenan SP, Wood G, Jiang X, Day AG, Laporta D, Klompas M; Canadian Critical Care Trials Group. The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. Chest. 2013; 144:1453–1460.

20. Netzer G, Dowdy DW, Harrington T, Chandolu S, Dinglas VD, Shah NG, Colantuoni E, Mendez-Tellez PA, Shanholtz C, Hasday JD, et al. Fever is associated with delayed ventilator liberation in acute lung injury. Ann Am Thorac Soc. 2013; 10:608–615.

21. Schell-Chaple HM, Puntillo KA, Matthay MA, Liu KD; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network. Body temperature and mortality in patients with acute respiratory distress syndrome. Am J Crit Care. 2015; 24:15–23.

22. Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, Tada K, Tanaka K, Ietsugu K, Uehara K, et al. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care. 2012; 16:R33.

23. Young PJ, Saxena M, Beasley R, Bellomo R, Bailey M, Pilcher D, Finfer S, Harrison D, Myburgh J, Rowan K. Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med. 2012; 38:437–444.

24. Young PJ, Saxena M. Fever management in intensive care patients with infections. Crit Care. 2014; 18:206.

25. Rello J, Quintana E, Ausina V, Castella J, Luquin M, Net A, Prats G. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest. 1991; 100:439–444.

26. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med. 1997; 336:912–918.

27. Young P, Saxena M, Bellomo R, Freebairn R, Hammond N, van Haren F, Holliday M, Henderson S, Mackle D, McArthur C, et al. Acetaminophen for fever in critically ill patients with suspected infection. N Engl J Med. 2015; 373:2215–2224.

28. Arons MM, Wheeler AP, Bernard GR, Christman BW, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson W, Wright P, et al. Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med. 1999; 27:699–707.

29. Garnacho-Montero J, Amaya-Villar R, García-Garmendía JL, Madrazo-Osuna J, Ortiz-Leyba C. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med. 2005; 33:349–354.

30. Kiekkas P, Aretha D, Baltopoulos GI. The continuing question of how fever duration is associated with patient outcome. Crit Care. 2012; 16:166.

31. Vidaur L, Gualis B, Rodriguez A, Ramírez R, Sandiumenge A, Sirgo G, Diaz E, Rello J. Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome. Crit Care Med. 2005; 33:1248–1253.

32. Dennesen PJ, van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med. 2001; 163:1371–1375.

33. Yagi N, Leblanc M, Sakai K, Wright EJ, Paganini EP. Cooling effect of continuous renal replacement therapy in critically ill patients. Am J Kidney Dis. 1998; 32:1023–1030.

34. Fagnoul D, Taccone FS, Belhaj A, Rondelet B, Argacha JF, Vincent JL, Backer DD. Extracorporeal life support associated with hypothermia and normoxemia in refractory cardiac arrest. Resuscitation. 2013; 84:1519–1524.